CoChat
Sign Up
Cited by 433Smoking Behavior and CessationNicotinic Acetylcholine Receptors StudySubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.

Nicotine receptor partial agonists for smoking cessation

Open access
Cahill, Kate, Lindson-Hawley, Nicola, Thomas, Kyla H, Fanshawe, Thomas R, Lancaster, Tim·2016·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd006103.pub7
Open this paper in CoChat — free accountOpen PDF

Abstract

Nicotine receptor partial agonists for smoking cessation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd006103.pub7

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. Aubin, 2008, Authors' reply [to JE Rose], Thorax, 63, 752
  2. Aubin, 2008, Authors' reply [to T Hillman], Thorax, 63, 752
  3. Brinn, 2013, Cost effectiveness of an inpatient smoking cessation intervention for patients with tobacco related illnesses (Stop Trial): a multi-centre RCT [Abstract], Respirology (Carlton, Vic.), 18, 16 [O027]
  4. Carson, 2015, Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomized controlled trial for inpatients, Respirology, 20, 115
  5. Carson, 2010, Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract], Respirology, 15, A30
  6. Hnin, 2014, Triggers resulting in relapse: cohort analysis from the smoking termination opportunity for inpatients (STOP) trial [Abstract], Respirology (Carlton, Vic.), 19, 40 [TO 076]
  7. Anthenelli R Benowitz N West R St Aubin L McRae T Lawrence D Reports of suicidal ideation and behavior in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
  8. Benowitz N Evins AE West R St Aubin L McRae T Lawrence D EAGLES trial: study design and neuropsychiatric safety results Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
  9. Prochaska J Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
  10. Prochaska J Benowitz N West R Anthenelli R Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled tiral comparing the safety and efficacy of the first-line smoking cessation aids in smokers with and without pychiatric disorders Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
  11. West R Benowitz N Evins AE St Aubin L McRae T Lawrence D Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
  12. Bastian H Comment on Ebbert 2015 'Reduce to Quit' trial www.ncbi.nlm.nih.gov/pubmed/?term=25688780
  13. Evins, 2013, Extended duration pharmacotherapy with varenicline prevents relapse to smoking in adult smokers with schizophrenia, Neuropsychopharmacology, 38, S63
  14. Meszaros, 2012, Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial, American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 21, 393
  15. Nakamura, 2007, Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers, Clinical Therapeutics, 29, 1040, 10.1016/j.clinthera.2007.06.012 · DOI
  16. Rigotti, 2010, A randomized trial of varenicline for smoking cessation in patients with cardiovascular disease: analysis of efficacy by baseline characteristics, Circulation, Conference, 2
  17. Benndorf, 1970, Smoking cessation treatment with cytisin (Tabex®): half-yearly outcomes for former smokers abstinent at four weeks from beginning of treatment, Das Deutsche Gesundheitwesen, 24, 774
  18. Benndorf, 1969, Further reports on a double blind trial of the Bulgarian cytisine compound Tabex® on 1214 smokers wishing to quit and practical experience in conducting clinics for such smokers, Das Deutsche Gesundheitswesen, 24, 1135
  19. Benndorf, 1968, Results of smoking cessation treatment with cytisin (Tabex®), Das Deutsche Gesundheitwesen, 23, 2092
  20. Scharfenberg, 1971, Cytisine (Tabex®) as a treatment for smoking cessation, Das Deutsche Gesundheitwesen, 26, 463
  21. O'Brien, 2007, Varenicline as maintenance therapy, Current Psychiatry Reports, 9, 348
  22. Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
  23. Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
  24. Westergaard, 2014, The effect of varenicline on smoking cessation in a group of young asthma patients, American Journal of Respiratory and Critical Care Medicine, 189, A1091
  25. Reeves K Watsky E Williams K Azoulay S Billing B Gong J The safety of varenicline taken for 52 weeks for smoking cessation [RPOS3-54] Society for Research on Nicotine and Tobacco 12th Annual Conference Orlando Fla, USA 2006
  26. Falk, 2014, A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence, Alcoholism, Clinical and Experimental Research, 38, 139A
  27. Granatowicz, 1976, Smoking cessation through the use of cytisine and other therapy, World Smoking Health, 1, 8
  28. Hartwell, 2014, Pharmacogenetics of naltrexone and varenicline in heavy drinking smokers, Alcoholism, Clinical and Experimental Research, 38, 223A
  29. Bacvarov, 1967, Smoking cessation through medication: remarks on G. Scharfenberg, E Winkelvoss and S. Benndorf, Munch Med Wschr. 109 (1967) 1687-1689, Munchener Medizinische Wochenschrift, 109, 2663
  30. Kempe, 1967, Observation about the Bulgarian medicine for smoking withdrawal Tabex, produced by Pharmachim-Sofia, Savr Med, 18, 355
  31. Paun, 1968, [Smoking cessation with cytisine 'Tabex' tablets] [German], Sonderduck aus das deutsche Gesundheitwesen, 23, 2088
  32. Paun, 1970, Tabex: registering and treatment of smokers with chronic bronchitis in the consultation against tobacco smoking - Berlin, Medico-Biologic Information, 3, 15
  33. Shim, 2011, Varenicline treatment for smoking cessation in people with schizophrenia: a randomized double-blind placebo-controlled trial, Schizophrenia Bulletin, 37, 320
  34. Stoyanov, 1972, [On the therapeutic effectiveness and tolerability of Tabex] [Bulgarian], Savremenna Medicina, 23, 30
  35. Wiratmoko, 2013, Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs placebo for smoking cessation. A randomized controlled trial, Respirology (Carlton, Vic.), 18, 66 [OS205]
  36. Reid, 2010, Varenicline versus transdermal nicotine patch for smoking cessation in patients with coronary heart disease: A pilot randomized trial, Canadian Journal of Cardiology, 26, 53D
  37. Smith, 2013, Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia, Neuropsychopharmacology, 38, S364
  38. Tutka, 2006, Cytisine - renaissance of well known alkaloid. Pharmacological aspects of efficacy in the treatment of tobacco dependence [Polish], Farmakoterapia w Psychiatrii i Neurologii, 1, 33

Cited by

Sorted by citations

See all 433

Related

See all

Metadata

Authors
Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T.
Affiliations
  • University of Oxford (GB)
  • University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG
  • University of Bristol (GB)
ORCID
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-05-09
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
DOI
10.1002/14651858.cd006103.pub7
OpenAlex
W4294253676
Cited by
433
References
230
Citations by year
2026: 5 · 2025: 22 · 2024: 32 · 2023: 57 · 2022: 55 · 2021: 65 · 2020: 34 · 2019: 52 · 2018: 49 · 2017: 43 · 2016: 8
FWCI
6.00
Type
journal article
Language
en
Update notices
new_version (2023-05-05)
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion)
  • Explore Bristol Research (submittedVersion, other-oa)
Funders
  • National Institute for Health and Care Research (15/58/18, HTA/15/58/18, CL-2013-25-003)
  • Academy of Medical Sciences (AMS-SGCL12-Thomas)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
nicotine receptor partial agonist, smoking cessation, nicotine replacement therapy, varenicline, bupropion, nicotine dependence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review